Clinical variability and female penetrance in X-linked familial FTD/ALS caused by a P506S mutation in UBQLN2

References

• Barson FP, Kinsella GJ, Ong B. Mathers SE. A neuropsychological investigation of dementia in motor neuron disease (MND). J Neurol Sci. 2000;180:107–13.
   PubMed Web of Science ®Google Scholar
• Lillo P, Mioshi E, Zoing MC, Kiernan MC, Hodges JR. How common are behavioural changes in amyotrophic lateral sclerosis?. Amyotroph Lateral Scler. 2011;12:45–51.
   PubMed Web of Science ®Google Scholar
• Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65: 586–90.
   PubMed Web of Science ®Google Scholar
• Neary D, Snowden JS, Mann DMA, Northen B, Goulding PJ, Macdermott N. Frontal lobe dementia and motor neuron disease. Cognitive change in motor neuron disease/amyotrophic lateral sclerosis (MND/ALS). J Neurol Sci. 2000; 180:1520.
   Web of Science ®Google Scholar
• Lomen-Hoerth C. Characterization of ALS and frontotemporal dementia. Dement Geriatr Cogn Disord. 2004;17: 337–41.
   PubMed Web of Science ®Google Scholar
• Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal?. Neurology. 2003;60:1094–7.
   PubMed Web of Science ®Google Scholar
• Chiò A, Ilardi A, Cammarosano S, Moglia C, Montuschi A, Calvo A. Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV. Neurology. 2012;78:1085–9.
   PubMed Web of Science ®Google Scholar
• Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011;76:1263–9.
   PubMed Web of Science ®Google Scholar
• Mitsuyama Y. Presenile dementia with motor neuron disease. Dementia. 1993;4:137–42.
   PubMedGoogle Scholar
• Yoshida M. Amyotrophic lateral sclerosis with dementia: the clinicopathological spectrum. Neuropathology. 2004;24: 87–102.
   PubMed Web of Science ®Google Scholar
• Hudson AJ. ALS and its association with dementia, Parkinsonism, and other neurological disorders: a review. Brain. 1981;104:217–47.
   PubMed Web of Science ®Google Scholar
• Portet F, Cadihac C, Touchon J, Camu W. Cognitive impairment in motor neuron disease with bulbar onset. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2:23–9.
   PubMed Web of Science ®Google Scholar
• Geser F, Martinez-Lage M, Kwong LK, Lee VM, Trojanowski JQ. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J Neurol. 2009;256:1205–14.
   PubMed Web of Science ®Google Scholar
• Giordana MT, Ferrero P, Grifoni S, Pellerino A, Naldi A, Montuschi A. Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review. Neurol Sci. 2011; 32:9–16.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9orf72 mutations. Brain. 2012;135:693–708.
   PubMed Web of Science ®Google Scholar
• Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211–5.
   PubMed Web of Science ®Google Scholar
• Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668–72.
   PubMed Web of Science ®Google Scholar
• N’Diaye EN, Hanyaloglu AC, Kajihara KK, Puthenveedu MA, Wu P, von Zastrow M, et al. The ubiquitin-like protein PLIC-2 is a negative regulator of G protein-coupled receptor endocytosis. Mol Biol Cell. 2008;19:1252–60.
   PubMedGoogle Scholar
• N’Diaye EN, Kajihara KK, Hsieh I, Morisaki H, Debnath J, Brown EJ. PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. EMBO Rep. 2009;10:173–9.
   PubMed Web of Science ®Google Scholar
• Tashiro Y, Urushitani M, Inoue H, Koike M, Uchiyama Y, Komatsu M, et al. Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis. J Biol Chem. 2012;287:42984–94.
   PubMed Web of Science ®Google Scholar
• Gellera C, Tiloca C, del Bo R, Corrado L, Pensato V, Agostini J, et al. Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2013;84:183–7.
   PubMed Web of Science ®Google Scholar
• DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in non-coding region of C9orf72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72: 245–56.
   PubMed Web of Science ®Google Scholar
• Kinsley L, Siddique T. Amyotrophic lateral sclerosis overview. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. GeneReviews^™ (Internet). Seattle (WA): University of Washington, Seattle; 1993 − 2001 Mar 23 (updated 2012 May 31).
   Google Scholar
• Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Wynne B, et al. Cognitive changes predict functional decline in ALS: a population based longitudinal study. Neurology. 2013; 80:1590–7.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9orf72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–68.
   PubMed Web of Science ®Google Scholar
• van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 pathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7:409–16.
   PubMed Web of Science ®Google Scholar
• Wicks P, Abrahams S, Papps B, Al-Chalabi A, Shaw CE, Leigh PN, et al. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis. Jour Neurol. 2009;256:234–41.
   PubMed Web of Science ®Google Scholar
• Katz JS, Katzberg HD, Wooley SC, Marklund SL, Andersen PM. Combined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an l113T SOD1 mutation. Amytroph Lateral Scler. 2012;13: 567–9.
   PubMed Web of Science ®Google Scholar
• Ng SB, Nickerson DA, Bamshad MJ, Shendure . Massively parallel sequencing and rare disease. J Hum Mol Genet. 2010;19:119–24.
   Web of Science ®Google Scholar
• Ogaki K, Li Y, Atsuta N, Tomiyama H, Funayama M, Watanabe H, et al. Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol Aging. 2012;2527:e11–6.
   Google Scholar
• Nogales-Gadea G, Garcia-Arumi E, Andreu AL, Cervera C, Gamez J. A novel exon 5 mutation (N139H) in the SOD1 gene in a Spanish family associated with incomplete penetrance. J Neurol Sci. 2004;219:1–6.
   PubMed Web of Science ®Google Scholar
• Conforti FL, Barone R, Fermo SL, Giliberto C, Patti F, Gambardella A, et al. Sporadic motor neuron disease in a familial novel SOD1 mutation: incomplete penetrance or chance association?. Amyotroph Lateral Scler. 2011; 12:220–2.
   PubMed Web of Science ®Google Scholar
• van Blitterswijk M, van Es MA, Hennekam EA, Dooijes D, van Rheenen W, Medic J, et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21:3776–84.
   PubMed Web of Science ®Google Scholar